Ed Carlsen, Special Administrator of the Estate of Donna Marie Carlsen, Deceased v. A. J. Javurek, M.D.

526 F.2d 202
CourtCourt of Appeals for the Eighth Circuit
DecidedDecember 19, 1975
Docket75--1023
StatusPublished
Cited by25 cases

This text of 526 F.2d 202 (Ed Carlsen, Special Administrator of the Estate of Donna Marie Carlsen, Deceased v. A. J. Javurek, M.D.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ed Carlsen, Special Administrator of the Estate of Donna Marie Carlsen, Deceased v. A. J. Javurek, M.D., 526 F.2d 202 (8th Cir. 1975).

Opinion

BRIGHT, Circuit Judge.

Donna Marie Carlsen underwent surgery at St. Joseph’s Hospital in Deadwood, South Dakota, on January 5, 1972, for an elective cholecystectomy (gall bladder removal). 1 The surgery was performed under Penthrane (Methoxyflurane), a general halogenated anesthetic. 2 Subsequent to surgery, Mrs. Carlsen developed a liver dysfunction which resulted in her death on January 17, 1972. Her husband, Ed Carlsen, as special administrator of Mrs. Carlsen’s estate, subsequently brought this suit for wrongful death alleging negligence on the part of the appellees relating to the selection and administration of Penthrane during the operation which proximátely caused Mrs. Carlsen’s fatal illness. Carlsen sought damages for himself as surviving husband, for the estate, and for his four children against the attending physician and assisting surgeon, Dr. A. J. Javurek; the operating surgeon, Dr. Rueben Trinidad; the nurse-anesthetist, Carol F. Johnson, and her employer, St. Joseph’s Hospital; and Abbott Laboratories, the manufacturer of Penthrane. The trial court directed a verdict in favor of Abbott Laboratories and the jury dismissed the action against the other defendants. Carlsen then brought this timely appeal from the judgment of dismissal.

After a thorough review of the record, we sustain the directed verdict and judgment dismissing Abbott Laboratories and the dismissal against Dr. Javurek, but reverse the judgment otherwise and direct that plaintiff be given a new trial against surgeon Trinidad, nurse Johnson, and her employer, St. Joseph’s Hospital. *205 Although the trial lasted over a period of eight days, the salient testimony bearing on liability is not unduly extensive nor complicated and we summarize it below.

I. Factual Background.

Donna Marie Carlsen entered St. Joseph’s Hospital for surgery on January 3, 1972, under the care of her physician, Dr. Javurek, a general practitioner in Deadwood, South Dakota. She had earlier complained of chronic epigastric distress which Dr. Javurek had determined was resulting from a malfunctioning gall bladder. Dr. Javurek called in Dr. Rueben Trinidad, a general surgeon practicing in the Lead-Deadwood-Spearfish, South Dakota, area, to perform the cholecystectomy. The admitting hospital history disclosed, among other things, that Mrs. Carlsen had suffered from hepatitis in 1956, during childhood.

Dr. Trinidad testified that he visited with Mrs. Carlsen on the day before surgery and advised her that she would be given a general anesthesia. He informed her of the risks , of surgery under a general anesthetic, including the risk of death. He further told Mrs. Carlsen that tests taken at the hospital showed her physical condition as generally normal but that because of her history of hepatitis there were “anesthetics that we probably would not be using.”

Dr. Trinidad testified he was aware that there were two schools of thought in the medical profession concerning the propriety of administering a halogenated anesthetic such as Penthrane to patients ■with a prior history of hepatitis; one school believing it is “absolutely o. k. to use” a halogenated anesthetic and the other school believing that “you may [want to] choose a different anesthetic.” In essence, Dr. Trinidad stated that he made a medical decision not to use Penthrane as an anesthesia in the surgery and communicated that decision to nurse Johnson.

Dr. Trinidad testified that he specifically told nurse Johnson not to use a halogenated anesthetic. At another point in his testimony he stated that while the nurse-anesthetist normally chose the anesthetic to be used, it was the “custom” in the hospital for the nurse-anesthetist to follow any direct orders from the surgeon. He added that he “assumed that she [nurse Johnson] would make a decision of her own considering my discussion, taking into consideration my suggestion, her knowledge of the patient, her knowledge with what the operation is going to be.” 3

Nurse Johnson admitted that she was obligated to follow a physician’s direct order relating to an anesthetic but in this case she specifically denied having any conversation with Dr. Trinidad prior to surgery and denied that Dr. Trinidad told her not to use a halogenated anesthetic. She stated that prior to surgery, she informed Dr. Javurek of her choice of anesthetic and that he merely raised his eyebrows and shrugged his shoulders. Dr. Javurek, however, denied this exchange. Dr. Javurek assisted in the surgery but testified that he did not participate in the selection of the anesthesia administered to Mrs. Carlsen. The testimony indicates that prior to the operation Dr. Javurek advised the circulating nurse to remind nurse Johnson of Mrs. Carlsen’s prior history of hepatitis.

The defendants presented an anesthesiologist, Dr. Michael Weingarten, director of the Department of Anesthesia at St. Francis Hospital in Milwaukee, Wisconsin, as an expert witness and introduced a report into evidence entitled the “National Halothane Study” to support the proposition that notwithstanding Mrs. Carlsen’s prior history of hepatitis 16 years earlier, Penthrane was the proper anesthetic for the operation. 4

*206 The package insert accompanying Penthrane contained the following relevant warnings:

PRECAUTIONS:
Cirrhosis, a history of viral hepatitis or other abnormalities involving liver dysfunction may be the - basis for selecting an anesthetic other than a halogenated agent * * *.
ADVERSE REACTIONS:
Hepatic dysfunction and fatal hepatic necrosis following Penthrane (Methoxyflurane) anesthesia have been reported * * *. (Emphasis added).

Dr. William K. Hamilton, chairman of the Department of Anesthesia at the University of California Medical Center in San Francisco, was deposed by appellees but plaintiff offered his video deposition on rebuttal. He indicated that other anesthetics might have been administered to a patient with a prior history of hepatitis; that the package insert accompanying the anesthesia serves to give the surgeon a choice of anesthesias; and that the surgeon is the “final responsible person” to select the anesthesia.

The parties disputed the cause of death. Her attending physician attributed her acute illness and death as “most probably” due to toxic hepatitis resulting from the apesthetic administered during surgery. Defendant’s expert witness testified that Mrs. Carlsen’s death was most likely caused by a viral hepatitis which had been in an incubating stage prior to surgery and thus had not been ascertainable through tests administered immediately prior to her operation.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Corley v. United States
D. Connecticut, 2025
Boone v. William W. Backus Hospital
864 A.2d 1 (Supreme Court of Connecticut, 2005)
Doe v. Milford Hospital, No. Cv97-0057258s (Jul. 26, 2000)
2000 Conn. Super. Ct. 8740 (Connecticut Superior Court, 2000)
Bourquin v. Melsungen
670 A.2d 1322 (Connecticut Appellate Court, 1996)
Northern Trust Co. v. Upjohn Co.
572 N.E.2d 1030 (Appellate Court of Illinois, 1991)
Koeniguer v. Eckrich
422 N.W.2d 600 (South Dakota Supreme Court, 1988)
Magbuhat v. Kovarik
382 N.W.2d 43 (South Dakota Supreme Court, 1986)
Carlson Min. Co. v. Titan Coal Co., Inc.
494 A.2d 1127 (Supreme Court of Pennsylvania, 1985)
Higgins v. Hicks Co.
756 F.2d 681 (Eighth Circuit, 1985)
Cheryll Laroche and Fritz Laroche v. United States
730 F.2d 538 (Eighth Circuit, 1984)
Moore v. VOLKSWAGENWERK, AG
575 F. Supp. 919 (D. Maryland, 1983)
United States v. Willie H. Dennis
625 F.2d 782 (Eighth Circuit, 1980)
Hill v. Squibb & Sons, ER
592 P.2d 1383 (Montana Supreme Court, 1979)
Pierluisi v. E. R. Squibb & Sons, Inc.
440 F. Supp. 691 (D. Puerto Rico, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
526 F.2d 202, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ed-carlsen-special-administrator-of-the-estate-of-donna-marie-carlsen-ca8-1975.